Cytokines Physiology
On this page
Direct answer
Cytokines are low-molecular-weight glycoprotein messengers — interleukins, interferons, tumour necrosis factors, colony-stimulating factors and chemokines — acting at picomolar to nanomolar concentrations through receptors linked to JAK-STAT and NF-kappaB pathways, most often autocrine or paracrine, and behaving pleiotropically (one cytokine, many actions) and redundantly (many cytokines, one action). The examinable anchors: IL-1 and TNF-alpha are the endogenous pyrogens driving fever through prostaglandin E2 in the hypothalamus and the acute-phase response; IL-2 grows T cells; IL-6 induces C-reactive protein; IL-4 switches B cells to IgE; IL-5 drives eosinophils; IL-12 commits TH1 cells; IL-17 organises neutrophilic inflammation; IL-10 is the chief anti-inflammatory brake.
What you must remember
- Fever mechanism: IL-1, TNF-alpha and IL-6 reach the organum vasculosum of the lamina terminalis, induce cyclo-oxygenase-2 and PGE2, and raise the hypothalamic set point — paracetamol works by blocking this step, not by cooling.
- Acute-phase response: IL-6 (with IL-1 and TNF) drives hepatocytes to make CRP (rising up to hundreds of fold within 24-48 hours), fibrinogen (the ESR story), serum amyloid A, while albumin falls — the laboratory face of inflammation.
- T-helper mapping: TH1 — IL-12 and IFN-gamma for intracellular organisms; TH2 — IL-4, IL-5, IL-13 for helminths and allergy; TH17 — IL-6 plus TGF-beta with IL-23 maintenance, for extracellular bacteria and autoimmunity.
- Allergy pair: IL-4 provides the IgE class switch and IL-5 the eosinophil arm — together they write the pathology of asthma and parasitic defence.
- Natural anti-inflammatory: IL-10 (from regulatory T cells and macrophages) shuts off macrophage cytokine output; IL-1 receptor antagonist (anakinra) is its drug-shelf cousin.
- Chemokine flagship: IL-8 (CXCL8), the neutrophil chemotaxin attracting the first wave to any bacterial focus.
- Interferons: type I (alpha and beta) establish the antiviral state in neighbouring cells; type II (IFN-gamma) activates macrophages — the macrophage's whistle for mycobacteria, deficient in its receptor pathway in children with disseminated BCG.
- Clinical arms of the network: TNF-alpha — septic shock, cachexia (anti-TNF: infliximab, etanercept); IL-6 — tocilizumab in rheumatoid arthritis and cytokine-release syndrome; IL-17 — secukinumab in psoriasis; IL-12/23 p40 — ustekinumab; G-CSF — filgrastim to rescue chemotherapy neutropenia.
- Cytokine storm: the runaway amplification seen in CAR-T therapy (IL-6-dominated, tocilizumab-responsive), haemophagocytic lymphohistiocytosis and severe sepsis — the same molecules that coordinate defence becoming lethal in excess.
A worked case: fever after CAR-T infusion
Three days after chimeric antigen receptor T-cell infusion for leukaemia, a young adult spikes a fever of 39.5°C with hypotension and a CRP and ferritin climbing steeply. Activated T cells and monocytes have flooded the circulation with IL-6, TNF-alpha and IL-1 — the textbook cytokine storm, graded clinically rather than by any single level. The physiology picks the drug: the IL-6 axis dominates CAR-T release syndrome, so the IL-6 receptor antibody tocilizumab is first-line (steroids are added for higher grades, a mirror image of sepsis where steroids are last-resort). Fever here is not the enemy — it is PGE2-mediated set-point elevation by IL-1 and IL-6, and the treating team's priority is the vascular leak and macrophage activation behind it, not the temperature on the chart.
How the exam frames it
Match-the-following questions on the interleukins are near-guaranteed. The recurring quartet: IL-1 (endogenous pyrogen, also called lymphocyte-activating factor historically), IL-2 (T-cell growth — and the therapeutic target of basiliximab in transplantation and the agent itself in renal cell carcinoma), IL-6 (CRP and B-cell differentiation), IL-4 (IgE). Two conceptual follow-ups separate ranks: why single-cytokine redundancy matters (knockouts are often mild because of overlap — but the fever mechanism has no redundant bypass for PGE2), and which cytokine is measured clinically (CRP as IL-6's surrogate — nobody orders an IL-6 in a district hospital).
Frequently asked questions
Which cytokines cause fever and by what mechanism?
IL-1, TNF-alpha and IL-6 act as endogenous pyrogens, inducing PGE2 in the OVLT region of the hypothalamus to raise the set point — the step paracetamol blocks.
Which cytokine drives C-reactive protein synthesis?
Interleukin-6, acting on hepatocytes; CRP can rise several hundred-fold within 48 hours and is the standard clinical surrogate of the IL-6 axis.
Which cytokines characterise TH1 and TH2 responses?
TH1 cells produce IFN-gamma (with IL-12 as their inducer) for intracellular pathogens; TH2 cells produce IL-4, IL-5 and IL-13 for helminths and allergic IgE responses.
What is the role of IL-17 in disease?
Produced by TH17 cells, it recruits neutrophils via chemokines and antimicrobial peptides; overactivity drives psoriasis, ankylosing spondylitis and other autoinflammatory patterns — the target of secukinumab.
What is cytokine release syndrome and its first-line drug?
A runaway IL-6- and TNF-dominated inflammatory syndrome after CAR-T therapy (and in HLH or severe sepsis), treated first-line in CAR-T cases with the IL-6 receptor antibody tocilizumab.